Sutro Biopharma, Inc. (STRO) Earnings Per Share (EPS)
Sutro Biopharma, Inc. (STRO) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2018-12-31 | N/A |
| 2019-12-31 | -$24.30 |
| 2020-12-31 | -$9.90 |
| 2021-12-31 | -$22.90 |
| 2022-12-31 | -$23.50 |
| 2023-12-31 | -$17.80 |
| 2024-12-31 | -$29.60 |
| 2025-12-31 | -$22.49 |
How STRO compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| MRNA | Moderna Inc. | -$7.26 |
| NKTR | Nektar Therapeutics | -$9.73 |
| PRGO | Perrigo Company plc | -$10.29 |
| QDEL | QuidelOrtho Corp Com | -$16.69 |
| NERV | — | -$34.67 |
These are five companies in the same sector as STRO with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Sutro Biopharma, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("STRO")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | STRO | $20.48 | +0.00% | 0.55M |
| 3 | ||||
| 4 | ||||
| 5 |